Constitutively high dNTP concentration inhibits cell cycle progression and the DNA damage checkpoint in yeast Saccharomyces cerevisiae

  1. Andrei Chabes*,, and
  2. Bruce Stillman*,
  1. *Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724; and
  2. Department of Medical Biochemistry and Biophysics, Umeå University, SE-901 87 Umeå, Sweden
  1. Contributed by Bruce Stillman, November 29, 2006 (received for review November 2, 2006)

Abstract

In eukaryotic cells the concentration of dNTP is highest in S phase and lowest in G1 phase and is controlled by ribonucleotide reductase (RNR). RNR activity is eliminated in all eukaryotes in G1 phase by a variety of mechanisms: transcriptional regulation, small inhibitory proteins, and protein degradation. After activation of RNR upon commitment to S phase, dATP feedback inhibition ensures that the dNTP concentration does not exceed a certain maximal level. It is not apparent why limitation of dNTP concentration is necessary in G1 phase. In principle, dATP feedback inhibition should be sufficient to couple dNTP production to utilization. We demonstrate that in Saccharomyces cerevisiae constitutively high dNTP concentration transiently arrests cell cycle progression in late G1 phase, affects activation of origins of replication, and inhibits the DNA damage checkpoint. We propose that fluctuation of dNTP concentration controls cell cycle progression and the initiation of DNA replication.

Footnotes

  • To whom correspondence may be addressed. andrei.chabes{at}medchem.umu.se or stillman{at}cshl.edu
  • Author contributions: A.C. and B.S. designed research; A.C. performed research; A.C. and B.S. contributed new reagents/analytic tools; A.C. and B.S. analyzed data; and A.C. and B.S. wrote the paper.

  • The authors declare no conflict of interest.

  • This article contains supporting information online at www.pnas.org/cgi/content/full/0610585104/DC1.

  • Abbreviations:
    RNR,
    ribonucleotide reductase;
    pre-RC,
    prereplicative complex;
    gal,
    galactose;
    MMS,
    methyl methanesulfonate;
    pre-IC,
    preinitiation complex;
    TMPK,
    thymidylate kinase;
    YPD,
    1% yeast extract/2% peptone/2% dextrose;
    YPGal,
    1% yeast extract/2% peptone/2% gal;
    YPRaf,
    1% yeast extract/2% peptone/2% raffinose.
« Previous | Next Article »Table of Contents